CORTEXA THERAPEUTICS
Mark Identification

CORTEXA THERAPEUTICS

Serial Number

99192698

Filing Date

May 19, 2025

Trademark by

CORTEXA THERAPEUTICS INC.

Classification Information

Biotechnology research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), Frontotemporal Dementia (FTD), Huntington’s Disease, and vascular dementia; Scientific research for medical purposes in the field of Central Nervous System (CNS) disorders; Scientific study and research in the field(s) of treatment and management of CNS disorders; Laboratory research services relating to pharmaceuticals; Clinical research in the field of Central Nervous System (CNS) disorders medical treatment; Testing of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of Central Nervous System (CNS) disorders treatments; Research and development services in the field of pharmaceutical preparations; Laboratory services for biomanufacturing CRO-contracted compounds; Laboratory research in the field of chemical analyses for analog development and PK/PD profiling; Pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development and consultation related thereto in the field of pharmaceutical therapeutic strategy and trial design advisory; Medical and scientific research in the field of Amyotrophic Lateral Sclerosis (ALS)

Computer and Scientific

Providing medical information in the field of Amyotrophic Lateral Sclerosis (ALS); Pharmaceutical advice; Providing health information in the field of Central Nervous System (CNS) disorders; Medical analysis services relating to the treatment of persons; Providing information in the field of the diagnosis and treatment of Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), Frontotemporal Dementia (FTD), Huntington’s Disease, and vascular dementia via a website; Consulting services in the field of the diagnosis and treatment of Amyotrophic Lateral Sclerosis (ALS); Consulting services to health care providers in the field of treating life-changing or life-threatening diseases; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of Central Nervous System (CNS) disorders; Medical screening services in the field of Central Nervous System (CNS) disorders

Medical, Beauty & Agricultural